Clinical Leadership & Infection Control

AHRQ Advises on Post-Shutdown Due Dates

The Agency for Healthcare Research and Quality has released a guide on agency deadlines affecting providers rescheduled due to the government shutdown earlier in October.

By: Staff

Friday, October 25th, 2013

Rescheduled activities include October application dates, peer review meetings and award actions.

From concept to impact: Standing up an office of well-being

Thursday, October 8

12:00 PM - 1:00 PM CDT

Presenters: Jim Gilligan, American Medical AssociationEve Poczatek, MBA, SPHR, Rush University System for Health

Beyond biopsy: Duke and Cleveland Clinic leaders on the next phase of prostate cancer care

Wednesday, October 7

11:00 AM - 12:00 PM CDT

Presenters: Rajan T. Gupta, MD, Duke Cancer Institute Center for Prostate & Urologic Cancers, Duke University Medical CenterDr. Srinivas Vourganti, MD, Cleveland Clinic, Glickman Urological & Kidney InstituteKevin Coady, PhilipsPaavo Immonen, Philips

Next Up in Clinical Leadership & Infection Control

First multi-cancer blood test nears FDA approval: What to know

A pivotal year for cancer blood tests An FDA advisory panel voted Sept. 23 in favor of approving Grail’s Galleri…

By: Elizabeth Gregerson
22 hours ago
Ohio system restructures board governance

Chillicothe, Ohio-based Adena Health will establish a system-level board of directors with five local advisory boards operating under its oversight.…

By: Kelly Gooch
23 hours ago
How Integrated Specialty Pharmacy Models Improve Patient Access, Adherence, and Outcomes

Sponsored

Specialty therapies continue to transform treatment across oncology, diabetes, rare disease, and other complex disease states. From 2020 to 2025,…

In collaboration with Shields Health Solutions
Yesterday

Comments are closed.

More Articles on Quality:

Next Up in Clinical Leadership & Infection Control

Join the 500,000+ healthcare executives who start their day with Becker's